Remikiren drug data and news

Remikiren drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Remikiren
Brand Names/Synonyms CCRIS 6519; Remikiren; Remikiren [Inn]
Indication For the treatment of hypertension and heart failure
Sponsored links
Description Not Available
Pharmacology Not Available
Mechanism Of Action Not Available
Remikiren News
(When available)
[an error occurred while processing this directive]
Dosage Forms Not Available
Drug_Category Antihypertensive Agents; ATC:C09XA01
Absorption Not Available
Interactions Not Available
Toxicity Not Available
Organisms Affected Humans and other mammals
Chemical IUPAC Name 2-benzyl-N-[1-[[1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxy-propyl]carbamoyl]-2-(3H-imidazol-4-yl)ethyl]-3-tert-butylsulfonyl-propanamide
Chemical Formula C33H50N4O6S
Molecular Weight 630.839 g/mol
Smiles String CC(C)(C)S(=O)(=O)CC(CC1=CC=CC=C1)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC3CCCCC3)C(C(C4CC4)O)O
Melting Point Not Available
Water Solubility Not Available
State Solid
LogP/Hphobicity 3.725
Isoelectric Point Not Available
Biotransformation Not Available
Half Life Not Available
Protein Binding [%] 83%
RxList Link Not Available>RXlist
Sponsored links
Drug Reference Not Available
Drug Type Approved Drug
Accession No APRD00163
CAS Registry Number 126222-34-2
KEGG Compound ID C07465
PubChem ID SID:9668
PharmGKB ID Not Available
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] Not Available

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org